EUCTR2005-001033-15-IT进行中（未招募）不适用
STUDY OF PITAVASTATIN 2 MG vs. SIMVASTATIN 20 MG AND PITAVASTATIN 4 MG vs. SIMVASTATIN 40 MG FOLLOWING UP-TITRATION IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR COMBINED DYSLIPIDEMIA
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
STUDY OF PITAVASTATIN 2 MG vs. SIMVASTATIN 20 MG AND PITAVASTATIN 4 MG vs. SIMVASTATIN 40 MG (FOLLOWING UP-TITRATION) IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR COMBINED DYSLIPIDEMIAPRIMARY HYPERCHOLESTEROLEMIA OR COMBINED DYSLIPIDEMIAMedDRA version: 7.1Level: LLTClassification code 10020604EUCTR2005-001033-15-GBKowa Research Europe Ltd.800
进行中（未招募）
不适用
STUDY OF PITAVASTATIN 2 MG vs. SIMVASTATIN 20 MG AND PITAVASTATIN 4 MG vs. SIMVASTATIN 40 MG (FOLLOWING UP-TITRATION) IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR COMBINED DYSLIPIDEMIAEUCTR2005-001033-15-FIKowa Research Europe Ltd.800
进行中（未招募）
不适用
STUDY OF PITAVASTATIN 4 MG vs. SIMVASTATIN 40 MG (FOLLOWING UP- TITRATION) IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR COMBINED DYSLIPIDEMIA AND 2 OR MORE RISK FACTORS FOR CORONARY HEART DISEASEHypercholesterolemia or Combined Dyslipidemia and 2 or more risk factors for coronary heart disease (CHD)MedDRA version: 7.1Level: LLTClassification code 10020604EUCTR2005-001037-15-GBKowa Research Europe Ltd.300
进行中（未招募）
不适用
STUDY OF PITAVASTATIN 4 MG vs. SIMVASTATIN 40 MG (FOLLOWING UP- TITRATION) IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR COMBINED DYSLIPIDEMIA AND 2 OR MORE RISK FACTORS FOR CORONARY HEART DISEASEHypercholesterolemia or Combined Dyslipidemia and 2 or more risk factors for coronary heart disease (CHD)MedDRA version: 7.1Level: LLTClassification code 10020604EUCTR2005-001037-15-SEKowa Research Europe Ltd.300
进行中（未招募）
不适用
STUDY OF PITAVASTATIN 4 MG vs. SIMVASTATIN 40 MG (FOLLOWING UP- TITRATION) IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR COMBINED DYSLIPIDEMIA AND 2 OR MORE RISK FACTORS FOR CORONARY HEART DISEASEHypercholesterolemia or Combined Dyslipidemia and 2 or more risk factors for coronary heart disease (CHD)MedDRA version: 7.1Level: LLTClassification code 10020604EUCTR2005-001037-15-DKKowa Research Europe Ltd.300